SCHEMBL9892413

SCHEMBL9892413

Cc1ccc(=O)n(-c2ccc(N)cc2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.67
KDM4E B2RXH2 3/20 0.67
HSD17B10 Q99714 2/20 0.67
CYP1A2 P05177 1/20 0.67
HPGD P15428 1/20 0.67
BLM P54132 1/20 0.67
MAPK14 Q16539 5/20 0.50
ACHE P22303 1/20 0.44
NPC1 O15118 2/20 0.42
TSHR P16473 2/20 0.42
RAB9A P51151 2/20 0.42
CASP7 P55210 2/20 0.42
CASP1 P29466 1/20 0.42
F2 P00734 1/20 0.42
ELANE P08246 1/20 0.42
CTSG P08311 1/20 0.42
CMA1 P23946 1/20 0.42
CTRC Q99895 1/20 0.42
MAPT P10636 4/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL356681 0.90 ALDH1A1 (0.80) ALDH1A1KDM4EHSD17B10CYP1A2HPGD
SCHEMBL3970272 0.88 ALDH1A1 (0.77) ALDH1A1KDM4EHSD17B10CYP1A2HPGD
SCHEMBL3307167 0.81 ALDH1A1 (0.67) ALDH1A1KDM4EHSD17B10CYP1A2HPGD
SCHEMBL3302369 0.81 ALDH1A1 (0.67) ALDH1A1KDM4EHSD17B10CYP1A2HPGD
SCHEMBL147877 0.81 ALDH1A1 (0.67) ALDH1A1KDM4EHSD17B10CYP1A2HPGD
Hydronidone SCHEMBL143564 0.81 ALDH1A1 (0.67) ALDH1A1KDM4EHSD17B10CYP1A2HPGD
SCHEMBL3975362 0.81 ALDH1A1 (0.67) ALDH1A1KDM4EHSD17B10CYP1A2HPGD
Pirfenidone SCHEMBL1006039 0.80 KDM4E (1.00) ALDH1A1KDM4EHSD17B10CYP1A2HPGD
SCHEMBL3306599 0.80 ALDH1A1 (0.66) ALDH1A1KDM4EHSD17B10CYP1A2HPGD
Pirfenidone SCHEMBL4708 0.80 KDM4E (1.00) ALDH1A1KDM4EHSD17B10CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118619937-A Benzotriazine double oxide and pharmaceutical composition thereof 浙江瑞臻医药有限公司 2024-09-10 CN disclosed
US-8426407-B2 Preparation of 1-(substituted aryl)-5-trifluoromethyl-2-(1H)pyridone compounds and salts thereof and their applications CENTRAL SOUTH UNIVERSITY (CN) 2013-04-23 US disclosed
US-20120142688-A1 PREPARATION OF 1-(SUBSTITUTED ARYL)-5-TRIFLUOROMETHYL-2-(1H)PYRIDONE COMPOUNDS AND SALTS THEREOF AND THEIR APPLICATIONS CENTRAL SOUTH UNIVERSITY (CN) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142688-A1 PREPARATION OF 1-(SUBSTITUTED ARYL)-5-TRIFLUOROMETHYL-2-(1H)PYRIDONE COMPOUNDS AND SALTS THEREOF AND THEIR APPLICATIONS CFTR, COL1A1, FN1 ALDH1A1 142/4885KDM4E 2004/4885HSD17B10 1439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.